Medicine
KADCYLA 100
Key ingredient(s)
0 Mg
Trastuzumab Emitansine
Trastuzumab Emtansine 100
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| INFUSION (PARENTERAL) | 100,0 mg | — | Parenteral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2bqjBDzGyFhCjJxk3jiHcdsa6Mjy6qP3EoW42hn_EaVOz3-2raj1XkOp75A4z-PhUgYry17GuPOTZNnY_7340TW9p2VskIpinpexiMrCe4sI5Q | Reg: 49/32.16/0197 | AppNo: 490197 | RegDate: 2019/06/26 | Applicant: Roche Products (Pty) Ltd | API: Trastuzumab Emitansine | Status: Registered